2009Medical Journal of Chinese People's HealthRequires access

Comparison study in the treatment of schizophrenia between quetiapine and clozapine

Chengcheng Zhang

Open publisher page 0 citations

Abstract

Objective:To compare the clinical efficacy and safety between quetiapine and clozapine in the treatment of schizophrenia. Methods: 120 patients with schizophrenia were randomly divided into two groups, quetiapine group and clozapine group for 12 weeks. Positive and negative symptom scale (PANSS), treatment emergent symptom scale (TESS), and short form 36 health survey questionnaire ( SF - 36 ) were used to evaluate the efficacy or safety. Results: The total scores of PANSS obviously decreased in both groups and there was no significant difference between the two groups after treatment ( P 0.05 ). The incidence rate of side effects in quetiapine group was significant lower than that in clozapine group (P 0.05 ). Conclusions: quetiapine is a safe and effective antipsy - chotic drug, with similar efficacy as clozapine and fewer side effects in the treatment of schizophrenia.

About this research paper

What this paper is about

Objective:To compare the clinical efficacy and safety between quetiapine and clozapine in the treatment of schizophrenia. Methods: 120 patients with schizophrenia were randomly divided into two groups, quetiapine group and clozapine group for 12 weeks. Positive and negative symptom scale (PANSS), treatment emergent symptom scale (TESS), and short form 36 health survey questionnaire ( SF - 36 ) were used to evaluate the efficacy or safety. Results: The total scores of PANSS obviously decreased in both groups and there was no significant difference between the two groups after treatment ( P 0.05 ). The incidence rate of side effects in quetiapine group was significant lower than that in clozapine group (P 0.05 ). Conclusions: quetiapine is a safe and effective antipsy - chotic drug, with similar efficacy as clozapine and fewer side effects in the treatment of schizophrenia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare the clinical efficacy and safety between quetiapine and clozapine in the treatment of schizophrenia. Methods: 120 patients with schizophrenia were randomly divided into two groups, quetiapine group and clozapine group for 12 weeks. Positive and negative symptom scale (PANSS), treatment emergent symptom scale (TESS), and short form 36 health survey questionnaire ( SF - 36 ) were used to evaluate the efficacy or safety. Results: The total scores of PANSS obviously decreased in both groups and there was no significant difference between the two groups after treatment ( P 0.05 ). The incidence rate of side effects in quetiapine group was significant lower than that in clozapine group (P 0.05 ). Conclusions: quetiapine is a safe and effective antipsy - chotic drug, with similar efficacy as clozapine and fewer side effects in the treatment of schizophrenia.

Key concepts: Quetiapine, Clozapine, Schizophrenia (object-oriented programming), Negative symptom, Medicine, Internal medicine, Clinical efficacy, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison study in the treatment of schizophrenia between quetiapine and clozapine — Research Paper | ScholarLens